Presenting Our November 2026 Theme: Emergency Psychiatry | Psychiatric Times
· psychiatrictimes.com · popularity 16/100 · 0 similar stories today
Read the original at psychiatrictimes.com →
Summary
October 31st, 2026 Alkermes launches a phase 2 trial of oral orexin-2 agonist ALKS 7290 to boost antidepressant response in major depressive disorder, …
Found in: Mental Health. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 16.